Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

With the MiSeq™ i100 Series, Illumina continues to set the highest standards.Advancements in system design, sequencing chemistry, and data analysis deliverthe simplest, fastest benchtop sequencing and ...

The next generation sequencing market offers significant opportunities by enhancing the diagnosis and treatment of chronic ...

Thiruvananthapuram: Rajiv Gandhi Centre for Biotechnology (RGCB) was selected as one of the four next-generation sequencing (NGS) hubs for Metagenomic.

AI-Powered systems and runway upgrades aim to significantly reduce flight disruptions from fog at Delhi's IGI airport.

The Rajiv Gandhi Centre for Biotechnology becomes a national Next-Generation Sequencing hub, aiming to combat acute febrile ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...

Delhi Airport has significantly strengthened its winter fog preparedness by deploying AI-driven systems, advanced predictive analytics and fully CAT-III compliant runways to ensure safer and smoother ...

MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can ...

TARGETED treatments for prostate cancer were a central theme at the European Society for Medical Oncology (ESMO) Congress ...

ServerDomes is partnering with Global Green Generation, a global engineering and construction management organization ...

The Global Targeted Sequencing Market is poised for growth due to rising demand for precise diagnostics in genetic disorders ...